368 related articles for article (PubMed ID: 18835745)
1. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis.
Ma J; Li H; Giovannucci E; Mucci L; Qiu W; Nguyen PL; Gaziano JM; Pollak M; Stampfer MJ
Lancet Oncol; 2008 Nov; 9(11):1039-47. PubMed ID: 18835745
[TBL] [Abstract][Full Text] [Related]
2. A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival.
Li H; Stampfer MJ; Mucci L; Rifai N; Qiu W; Kurth T; Ma J
Clin Chem; 2010 Jan; 56(1):34-43. PubMed ID: 19910504
[TBL] [Abstract][Full Text] [Related]
3. Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer.
Hammarsten J; Högstedt B
Eur J Cancer; 2005 Dec; 41(18):2887-95. PubMed ID: 16243513
[TBL] [Abstract][Full Text] [Related]
4. Association between C-peptide concentration and prostate cancer incidence in the CLUE II cohort study.
Lai GY; Helzlsouer KJ; Clipp SL; Rifai N; Platz EA
Cancer Prev Res (Phila); 2010 Oct; 3(10):1334-41. PubMed ID: 20858760
[TBL] [Abstract][Full Text] [Related]
5. A Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Murphy N; Cross AJ; Abubakar M; Jenab M; Aleksandrova K; Boutron-Ruault MC; Dossus L; Racine A; Kühn T; Katzke VA; Tjønneland A; Petersen KE; Overvad K; Quirós JR; Jakszyn P; Molina-Montes E; Dorronsoro M; Huerta JM; Barricarte A; Khaw KT; Wareham N; Travis RC; Trichopoulou A; Lagiou P; Trichopoulos D; Masala G; Krogh V; Tumino R; Vineis P; Panico S; Bueno-de-Mesquita HB; Siersema PD; Peeters PH; Ohlsson B; Ericson U; Palmqvist R; Nyström H; Weiderpass E; Skeie G; Freisling H; Kong SY; Tsilidis K; Muller DC; Riboli E; Gunter MJ
PLoS Med; 2016 Apr; 13(4):e1001988. PubMed ID: 27046222
[TBL] [Abstract][Full Text] [Related]
6. Body mass index in relation to serum prostate-specific antigen levels and prostate cancer risk.
Bonn SE; Sjölander A; Tillander A; Wiklund F; Grönberg H; Bälter K
Int J Cancer; 2016 Jul; 139(1):50-7. PubMed ID: 26914149
[TBL] [Abstract][Full Text] [Related]
7. Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial.
Kelly SP; Graubard BI; Andreotti G; Younes N; Cleary SD; Cook MB
J Natl Cancer Inst; 2017 Mar; 109(3):. PubMed ID: 27754927
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of plasma C-peptide and colorectal cancer risk in men.
Ma J; Giovannucci E; Pollak M; Leavitt A; Tao Y; Gaziano JM; Stampfer MJ
J Natl Cancer Inst; 2004 Apr; 96(7):546-53. PubMed ID: 15069117
[TBL] [Abstract][Full Text] [Related]
9. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Grubb RL; Black A; Izmirlian G; Hickey TP; Pinsky PF; Mabie JE; Riley TL; Ragard LR; Prorok PC; Berg CD; Crawford ED; Church TR; Andriole GL;
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):748-51. PubMed ID: 19258472
[TBL] [Abstract][Full Text] [Related]
10. Inverse correlation between body mass index and clinical outcomes in men with advanced castration-recurrent prostate cancer.
Halabi S; Ou SS; Vogelzang NJ; Small EJ
Cancer; 2007 Oct; 110(7):1478-84. PubMed ID: 17665494
[TBL] [Abstract][Full Text] [Related]
11. Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database.
Ho T; Gerber L; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
Eur Urol; 2012 Nov; 62(5):910-6. PubMed ID: 22921964
[TBL] [Abstract][Full Text] [Related]
12. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
[TBL] [Abstract][Full Text] [Related]
13. Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Barrington WE; Schenk JM; Etzioni R; Arnold KB; Neuhouser ML; Thompson IM; Lucia MS; Kristal AR
JAMA Oncol; 2015 Jun; 1(3):342-9. PubMed ID: 26181184
[TBL] [Abstract][Full Text] [Related]
14. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.
Bañez LL; Hamilton RJ; Partin AW; Vollmer RT; Sun L; Rodriguez C; Wang Y; Terris MK; Aronson WJ; Presti JC; Kane CJ; Amling CL; Moul JW; Freedland SJ
JAMA; 2007 Nov; 298(19):2275-80. PubMed ID: 18029831
[TBL] [Abstract][Full Text] [Related]
15. Association of body mass index and prostate cancer mortality.
Haque R; Van Den Eeden SK; Wallner LP; Richert-Boe K; Kallakury B; Wang R; Weinmann S
Obes Res Clin Pract; 2014; 8(4):e374-81. PubMed ID: 25091359
[TBL] [Abstract][Full Text] [Related]
16. Body mass index and mortality in men with prostate cancer.
Cantarutti A; Bonn SE; Adami HO; Grönberg H; Bellocco R; Bälter K
Prostate; 2015 Aug; 75(11):1129-36. PubMed ID: 25929695
[TBL] [Abstract][Full Text] [Related]
17. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
18. Body mass index is associated with higher Gleason score and biochemical recurrence risk following radical prostatectomy in Chinese men: a retrospective cohort study and meta-analysis.
Bai PD; Hu MB; Xu H; Zhu WH; Hu JM; Yang T; Jiang HW; Ding Q
World J Surg Oncol; 2015 Nov; 13():311. PubMed ID: 26542246
[TBL] [Abstract][Full Text] [Related]
19. Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition.
Stroup SP; Cullen J; Auge BK; L'Esperance JO; Kang SK
Cancer; 2007 Sep; 110(5):1003-9. PubMed ID: 17614338
[TBL] [Abstract][Full Text] [Related]
20. Obesity and prostate cancer detection: insights from three national surveys.
Parekh N; Lin Y; Dipaola RS; Marcella S; Lu-Yao G
Am J Med; 2010 Sep; 123(9):829-35. PubMed ID: 20800152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
